Holen Sie sich die Stockscreener-App
13.89
0.32%
-0.09
Schlusskurs vom Vortag:
$13.98
Offen:
$13.99
24-Stunden-Volumen:
168.87K
Relative Volume:
0.11
Marktkapitalisierung:
$821.40M
Einnahmen:
$122.29M
Nettoeinkommen (Verlust:
$122.31M
KGV:
6.4488
EPS:
2.1539
Netto-Cashflow:
$12.00M
1W Leistung:
-0.54%
1M Leistung:
+31.34%
6M Leistung:
+67.69%
1J Leistung:
+43.07%
1-Tages-Spanne:
$13.78
$14.37
1-Wochen-Bereich:
$13.53
$14.58
52-Wochen-Spanne:
$7.16
$14.58
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Firmenname
Zevra Therapeutics Inc
Sektor
Branche
Telefon
(888) 958-1253
Adresse
101 FEDERAL STREET, BOSTON
Compare ZVRA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
13.89 | 847.71M | 122.29M | 122.31M | 12.00M | 2.1539 |
VRTX
Vertex Pharmaceuticals Inc
|
517.75 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.65 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
924.22 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
308.30 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
193.45 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Eingeleitet | BTIG Research | Buy |
| 2025-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-08 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Eingeleitet | Guggenheim | Buy |
| 2024-09-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-09-24 | Bestätigt | Maxim Group | Buy |
| 2024-04-02 | Bestätigt | Maxim Group | Buy |
| 2024-03-12 | Eingeleitet | William Blair | Outperform |
| 2023-03-17 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten
(ZVRA) Risk Channels and Responsive Allocation - Stock Traders Daily
ZVRAZevra Therapeutics Inc Latest SEC Filings - Finviz
Enterprise value to revenue forward of Zevra Therapeutics, Inc. – NASDAQ:ZVRA - TradingView
Zevra Therapeutics, Inc.(NasdaqGS: ZVRA) added to Russell 2000 Value Benchmark - marketscreener.com
Zevra Therapeutics, Inc.(NasdaqGS:ZVRA) added to Russell Microcap Value Benchmark Index - marketscreener.com
Zevra Therapeutics, Inc.(NasdaqGS: ZVRA) added to Russell 2000 Value-Defensive Index - marketscreener.com
Zevra Therapeutics, Inc.(NasdaqGS: ZVRA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Price to book forward of Zevra Therapeutics, Inc. – DUS:1GDA - TradingView
Zevra Therapeutics, Inc.(NasdaqGS: ZVRA) added to Russell 2000 Defensive Index - marketscreener.com
Price to sales forward of Zevra Therapeutics, Inc. – NASDAQ:ZVRA - TradingView
Price to sales forward of Zevra Therapeutics, Inc. – DUS:1GDA - TradingView
Enterprise value to EBIT forward of Zevra Therapeutics, Inc. – NASDAQ:ZVRA - TradingView
Enterprise value to EBITDA forward of Zevra Therapeutics, Inc. – DUS:1GDA - TradingView
Zevra Therapeutics, Inc. Actuals & Estimates (SWB:1GDA) - TradingView
Zevra Therapeutics, Inc. Actuals & Estimates (TRADEGATE:1GDA) - TradingView
Zevra Therapeutics, Inc. Actuals & Estimates (NASDAQ:ZVRA) - TradingView
Zevra Therapeutics, Inc. Actuals & Estimates (DUS:1GDA) - TradingView
1GDA Forecast — Price Target — Prediction for 2027 - TradingView
ZVRA Forecast — Price Target — Prediction for 2027 - TradingView
William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating - Moomoo
H.C. Wainwright reiterates Zevra Therapeutics stock rating on infant study data - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC) - Sahm
Zevra Therapeutics chief legal & compliance sells $438,303 in stock By Investing.com - Investing.com South Africa
Form 4 Zevra Therapeutics Inc For: 23 June By Investing.com - Investing.com South Africa
ZVRA: Zevra Therapeutics Releases Positive Findings on Arimoclom - GuruFocus
Zevra Therapeutics chief legal & compliance sells $438,303 in stock - Investing.com
Zevra Therapeutics (ZVRA) legal chief sells shares after RSU exercise - Stock Titan
ZVRA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $26 - GuruFocus
Zevra Therapeutics reports positive MIPLYFFA pediatric data - grafa.com
H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $26 - Moomoo
(ZVRA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Alicia Secor Takes A Bullish Stance, Acquiring $51K Worth Of Zevra Therapeutics Stock Options - Benzinga
Director at Zevra Therapeutics (ZVRA) granted 30,000 stock options - Stock Titan
Zevra Therapeutics (ZVRA) director awarded 30,000 options at $11.17 strike - Stock Titan
Board member at Zevra (NASDAQ: ZVRA) receives 30,000-share option grant - Stock Titan
Zevra Therapeutics (ZVRA) awards director 30,000 stock options - Stock Titan
Zevra Therapeutics (NASDAQ: ZVRA) director gets 30,000 stock options grant - Stock Titan
Zevra Therapeutics (ZVRA) director awarded 30,000 stock options at set price - Stock Titan
Zevra Therapeutics Inc (ZVRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zevra Therapeutics Inc (ZVRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zevra Therapeutics Inc (ZVRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zevra Therapeutics Inc (ZVRA) Institutional Confidence - TradingKey
Zevra Therapeutics Inc (ZVRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Zevra Therapeutics Inc (ZVRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Zevra Therapeutics Inc (ZVRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Zevra Therapeutics Inc (ZVRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Zevra Therapeutics Inc (ZVRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? - Stocktwits
Zevra Therapeutics Is Maintained at Buy by Maxim Group - Moomoo
Finanzdaten der Zevra Therapeutics Inc-Aktie (ZVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zevra Therapeutics Inc-Aktie (ZVRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thompson Rahsaan | Chief Legal & Compliance |
May 11 '26 |
Sale |
11.30 |
1,794 |
20,272 |
48,125 |
2.28%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):